XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
REVENUES:    
Rental revenues $ 137,360 $ 124,027
Management, development and leasing fees 1,317 1,905
Other 3,091 3,185
Total revenues [1],[2] 141,768 129,117
EXPENSES:    
Property operating (25,878) (23,827)
Depreciation and amortization (45,541) (38,040)
Real estate taxes (15,731) (9,269)
Maintenance and repairs (13,466) (9,938)
General and administrative (20,707) (20,414)
Loss on impairment   (836)
Litigation settlement   68
Total expenses (121,323) (102,256)
OTHER INCOME (EXPENSES):    
Interest and other income 3,468 4,004
Interest expense (44,225) (39,812)
Loss on extinguishment of debt (217)  
Gain on sales of real estate assets 21,532 3,721
Income tax benefit 471 158
Equity in earnings of unconsolidated affiliates 6,913 4,594
Total other expenses, net (12,058) (27,335)
Net income (loss) 8,387 (474)
Net income (loss) attributable to common shareholders    
Operating Partnership (6)  
Other consolidated subsidiaries 408 524
Net income attributable to the Company 8,789 50
Earnings allocable to unvested restricted stock (577) (259)
Net income (loss) attributable to common shareholders $ 8,212 $ (209)
Basic and diluted per share data attributable to common shareholders:    
Basic earnings per share $ 0.27 $ (0.01)
Diluted earnings per share [3] $ 0.27 $ (0.01)
Weighted-average basic shares 30,419 31,546
Weighted-average diluted shares [3] 30,709 31,546
[1] Management, development and leasing fees earned by the Management Company are included in the All Other category. See Note 3 for information on the Company’s revenues disaggregated by revenue source.
[2] Sales taxes are excluded from revenues.
[3] For the three months ended March 31, 2025, the computation of diluted EPS does not include contingently issuable shares related to unvested restricted stock awards due to their anti-dilutive nature. Had the contingently issuable shares been dilutive, the denominator for diluted EPS would have been 30,825,915, including 116,802 contingently issuable shares related to unvested restricted stock awards. For the three months ended March 31, 2024, the computation of diluted EPS does not include contingently issuable shares related to unvested restricted stock awards due to their anti-dilutive nature. For the three months ended March 31, 2024, had the contingently issuable shares been dilutive, the denominator for diluted EPS would have been 31,568,257, including 22,536 contingently issuable shares related to unvested restricted stock awards.